Gary Cornelis Geelhoed
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Gary Cornelis Geelhoed has a total of 4 co-authors. Here are the top co-authors by number of shared publications:
Milana Dobrovoljac
Emergency Department, Princess Margaret Hospital for Children, Perth, Western Australia, Australia
2 shared publications- Nicholas de Klerk
Wesfarmers Centre of Vaccines and Infectious Diseases, Telethon Kids Institute, The University of Western Australia, Perth, WA, Australia
2 shared publications - Elizabeth Geelhoed
School of Population Health, University of Western Australia, Crawley, Australia
1 shared publication Nicholas H Klerk
Telethon Institute for Child Health Research, Perth, WA
1 shared publication
Latest Publications
- 7 May 2012
- Published by AMPCo in Medical Journal of Australia
- Vol. 196 (8) , 500
Emergency department overcrowding and mortality after the introduction of the 4‐hour rule in Western Australia
- 7 May 2012
- Published by AMPCo in Medical Journal of Australia
- Vol. 196 (8) , 500
Emergency department overcrowding and mortality after the introduction of the 4‐hour rule in Western Australia
- 6 February 2012
- Published by AMPCo in Medical Journal of Australia
- Vol. 196 (2) , 122-126
Emergency department overcrowding, mortality and the 4‐hour rule in Western Australia
Objective: To assess whether emergency department (ED) overcrowding was reduced after the introduction of the 4‐hour rule in Western Australia and whether any changes in overcrowding were associated ...
- 6 February 2012
- Published by AMPCo in Medical Journal of Australia
- Vol. 196 (2) , 122-126
Emergency department overcrowding, mortality and the 4‐hour rule in Western Australia
Objective: To assess whether emergency department (ED) overcrowding was reduced after the introduction of the 4‐hour rule in Western Australia and whether any changes in overcrowding were associated ...
- 4 September 2011
- Published by Wiley in Emergency Medicine Australasia
- Vol. 24 (1) , 79-85
How fast does oral dexamethasone work in mild to moderately severe croup? A randomized double‐blinded clinical trial
Objective: For children with croup controversy remains over dosage and time to onset of action of oral steroids. The Cochrane Collaboration and other reviews have suggested 0.6 mg/kg dexamethasone be used (despite some evidence that 0.15 mg/kg is effective) with no expectation of benefit before 4–6 h. This randomized double‐blinded clinical trial examines whether 0.15 mg/kg dexamethasone works by 30 min.Methods: Children with croup aged above 6 months presenting to a tertiary paediatric ED with a Westley croup score of mild to moderate range (scores 1–6 out of 17) were randomized to receive either 0.15 mg/kg dexamethasone or oral placebo solution. Vital signs and croup score were recorded at study entry and every 10 min up to 1 h after administration of the study drug. The main outcome measure was croup score at 30 min.Results: Each group contained 35 children. Baseline characteristics were similar, except for respiratory rate, which was higher in the placebo group. There was a growing trend to a lower croup score in the dexamethasone group, evident from 10 min and statistically significant from 30 min.Conclusion: For children with croup an oral dose of 0.15 mg/kg dexamethasone offers benefit by 30 min, much earlier than the 4 h suggested by the Cochrane Collaboration. This result might encourage doctors to treat more children with all severities of croup being less worried about potential side‐effects and delayed benefit.
- 4 September 2011
- Published by Wiley in Emergency Medicine Australasia
- Vol. 24 (1) , 79-85
How fast does oral dexamethasone work in mild to moderately severe croup? A randomized double‐blinded clinical trial
Objective: For children with croup controversy remains over dosage and time to onset of action of oral steroids. The Cochrane Collaboration and other reviews have suggested 0.6 mg/kg dexamethasone be used (despite some evidence that 0.15 mg/kg is effective) with no expectation of benefit before 4–6 h. This randomized double‐blinded clinical trial examines whether 0.15 mg/kg dexamethasone works by 30 min.Methods: Children with croup aged above 6 months presenting to a tertiary paediatric ED with a Westley croup score of mild to moderate range (scores 1–6 out of 17) were randomized to receive either 0.15 mg/kg dexamethasone or oral placebo solution. Vital signs and croup score were recorded at study entry and every 10 min up to 1 h after administration of the study drug. The main outcome measure was croup score at 30 min.Results: Each group contained 35 children. Baseline characteristics were similar, except for respiratory rate, which was higher in the placebo group. There was a growing trend to a lower croup score in the dexamethasone group, evident from 10 min and statistically significant from 30 min.Conclusion: For children with croup an oral dose of 0.15 mg/kg dexamethasone offers benefit by 30 min, much earlier than the 4 h suggested by the Cochrane Collaboration. This result might encourage doctors to treat more children with all severities of croup being less worried about potential side‐effects and delayed benefit.
- 29 July 2009
- Published by Wiley in Emergency Medicine Australasia
- Vol. 21 (4) , 309-314
27 years of croup: An update highlighting the effectiveness of 0.15 mg/kg of dexamethasone
Objective: To update an earlier observational study (1980–1995) documenting dramatic improvements in the management of croup with the mandatory use of a single oral dose of dexamethasone and to ascertain whether a reduction from a dose of 0.6 to 0.15 mg/kg in 1995 maintained these improved outcomes over the next 11 years.Methods: We evaluated retrospectively the experience of children with croup in Princess Margaret Hospital for Children, the only tertiary paediatric hospital in Western Australia, over the subsequent 11 year period from 1996 to 2006 inclusive. Data were updated from ED, general hospital and the intensive care unit records to show the numbers of children presenting to the hospital, admitted, transferred to intensive care and intubated. We also recorded the length of hospital stay and representation rate of all cases within 7 days.Results: The dramatic improvements in outcomes for croup, including reduced admission rates, length of stay, transfers to the intensive care unit, intensive care unit days and number of intubations as reported in our earlier paper, were maintained using 0.15 mg/kg dexamethasone. Admission rates for croup have fallen from 30% in the early 1990s to less than 15% in recent years, whereas the representation rate has risen slightly.Conclusion: The improved outcomes for children with croup presenting to our paediatric ED have been maintained with a reduced, single oral dose of 0.15 mg/kg of dexamethasone.
- 29 July 2009
- Published by Wiley in Emergency Medicine Australasia
- Vol. 21 (4) , 309-314
27 years of croup: An update highlighting the effectiveness of 0.15 mg/kg of dexamethasone
Objective: To update an earlier observational study (1980–1995) documenting dramatic improvements in the management of croup with the mandatory use of a single oral dose of dexamethasone and to ascertain whether a reduction from a dose of 0.6 to 0.15 mg/kg in 1995 maintained these improved outcomes over the next 11 years.Methods: We evaluated retrospectively the experience of children with croup in Princess Margaret Hospital for Children, the only tertiary paediatric hospital in Western Australia, over the subsequent 11 year period from 1996 to 2006 inclusive. Data were updated from ED, general hospital and the intensive care unit records to show the numbers of children presenting to the hospital, admitted, transferred to intensive care and intubated. We also recorded the length of hospital stay and representation rate of all cases within 7 days.Results: The dramatic improvements in outcomes for croup, including reduced admission rates, length of stay, transfers to the intensive care unit, intensive care unit days and number of intubations as reported in our earlier paper, were maintained using 0.15 mg/kg dexamethasone. Admission rates for croup have fallen from 30% in the early 1990s to less than 15% in recent years, whereas the representation rate has risen slightly.Conclusion: The improved outcomes for children with croup presenting to our paediatric ED have been maintained with a reduced, single oral dose of 0.15 mg/kg of dexamethasone.
- 1 January 2008
- Published by BMJ in Archives of Disease in Childhood
- Vol. 93 (1) , 62-64
Positive impact of increased number of emergency consultants
The increased presence of consultant staff should theoretically lead to better outcomes in emergency departments (EDs). A retrospective observational study was conducted in a tertiary paediatric emergency department (PED) over a 10-year period documenting trends in percentage of children admitted, complaints to the department and average waiting times. Consultant numbers increased from 2.6 to 6.2 full time equivalent staff between 2000 and 2004. Other staffing numbers were essentially unchanged. All parameters examined improved coincident with increasing consultant numbers. The percentage of children admitted decreased by 27%, complaints fell by 41% and the average waiting time by 15%. The yearly cost of an additional 3.6 consultants (2005) was $A1 003 490 with net saving to the hospital of over $A9.48 million. The provision of additional consultant medical staff in a PED coincided with a decrease in the percentage of children admitted, complaints to the department and average waiting times, and was cost effective.
- 1 January 2008
- Published by BMJ in Archives of Disease in Childhood
- Vol. 93 (1) , 62-64
Positive impact of increased number of emergency consultants
The increased presence of consultant staff should theoretically lead to better outcomes in emergency departments (EDs). A retrospective observational study was conducted in a tertiary paediatric emergency department (PED) over a 10-year period documenting trends in percentage of children admitted, complaints to the department and average waiting times. Consultant numbers increased from 2.6 to 6.2 full time equivalent staff between 2000 and 2004. Other staffing numbers were essentially unchanged. All parameters examined improved coincident with increasing consultant numbers. The percentage of children admitted decreased by 27%, complaints fell by 41% and the average waiting time by 15%. The yearly cost of an additional 3.6 consultants (2005) was $A1 003 490 with net saving to the hospital of over $A9.48 million. The provision of additional consultant medical staff in a PED coincided with a decrease in the percentage of children admitted, complaints to the department and average waiting times, and was cost effective.
- 1 June 2005
- Published by Wolters Kluwer Health in Pediatric Emergency Care
- Vol. 21 (6) , 359-362
Budesonide Offers No Advantage When Added to Oral Dexamethasone in the Treatment of Croup
To evaluate the effect of adding inhaled budesonide (2 mg) to oral dexamethasone 0.15 mg/kg in children hospitalized with croup. Observation ward of a Tertiary Paediatric Hospital Emergency Department. Seventy-two children (age range 3 to 126 months) hospitalized with croup. Children randomized to receive either 2 mg of nebulized budesonide or placebo, with all children receiving a single oral dose of 0.15 mg/kg dexamethasone. Primary outcome was duration of hospital stay. Other measures included croup scores from 0 to 12 hours, use of nebulized epinephrine, duration of croup symptoms, duration of viral symptoms, and return to medical care for croup or for any other reason following discharge from hospital. Baseline characteristics for the 2 groups were similar. There was no difference in time to discharge for the 2 groups or for other outcome measures with a risk ratio of 1.3 (95% confidence intervals of 0.82 and 2.1). The addition of inhaled budesonide (2 mg) to oral dexamethasone (0.15 mg/kg) offers no advantage in the treatment of children hospitalized with croup.
- 1 June 2005
- Published by Wolters Kluwer Health in Pediatric Emergency Care
- Vol. 21 (6) , 359-362
Budesonide Offers No Advantage When Added to Oral Dexamethasone in the Treatment of Croup
To evaluate the effect of adding inhaled budesonide (2 mg) to oral dexamethasone 0.15 mg/kg in children hospitalized with croup. Observation ward of a Tertiary Paediatric Hospital Emergency Department. Seventy-two children (age range 3 to 126 months) hospitalized with croup. Children randomized to receive either 2 mg of nebulized budesonide or placebo, with all children receiving a single oral dose of 0.15 mg/kg dexamethasone. Primary outcome was duration of hospital stay. Other measures included croup scores from 0 to 12 hours, use of nebulized epinephrine, duration of croup symptoms, duration of viral symptoms, and return to medical care for croup or for any other reason following discharge from hospital. Baseline characteristics for the 2 groups were similar. There was no difference in time to discharge for the 2 groups or for other outcome measures with a risk ratio of 1.3 (95% confidence intervals of 0.82 and 2.1). The addition of inhaled budesonide (2 mg) to oral dexamethasone (0.15 mg/kg) offers no advantage in the treatment of children hospitalized with croup.